Cargando…
Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study
Background and Objectives: Inflammatory bowel disease (IBD) is a condition characterized by chronic intestinal inflammation. We can identify two major forms: Crohn’s disease (CD) and ulcerative colitis (UC). One of the extraintestinal manifestations of IBD is nonalcoholic fatty liver disease (NAFLD)...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673463/ https://www.ncbi.nlm.nih.gov/pubmed/38003983 http://dx.doi.org/10.3390/medicina59111935 |
_version_ | 1785140628637614080 |
---|---|
author | Abenavoli, Ludovico Spagnuolo, Rocco Scarlata, Giuseppe Guido Maria Scarpellini, Emidio Boccuto, Luigi Luzza, Francesco |
author_facet | Abenavoli, Ludovico Spagnuolo, Rocco Scarlata, Giuseppe Guido Maria Scarpellini, Emidio Boccuto, Luigi Luzza, Francesco |
author_sort | Abenavoli, Ludovico |
collection | PubMed |
description | Background and Objectives: Inflammatory bowel disease (IBD) is a condition characterized by chronic intestinal inflammation. We can identify two major forms: Crohn’s disease (CD) and ulcerative colitis (UC). One of the extraintestinal manifestations of IBD is nonalcoholic fatty liver disease (NAFLD). IBD and NAFLD share common pathogenetic mechanisms. Ultrasound (US) examination is the most commonly used imaging method for the diagnosis of NAFLD. This cross-sectional observational retrospective study aimed to evaluate the US prevalence of NAFLD in IBD patients and their clinical features. Materials and Methods: A total of 143 patients with IBD underwent hepatic US and were divided into two different groups according to the presence or absence of NAFLD. Subsequently, new exclusion criteria for dysmetabolic comorbidities (defined as plus) were applied. Results: The US prevalence of NAFLD was 23% (21% in CD and 24% in UC, respectively). Most IBD–NAFLD patients were male and older and showed significantly higher values for body mass index, waist circumference, disease duration, and age at onset than those without NAFLD. IBD–NAFLD patients showed a significantly higher percentage of stenosing phenotype and left-side colitis. Regarding metabolic features, IBD–NAFLD patients showed a significantly higher percentage of hypertension and IBD plus dysmetabolic criteria. Also, higher values of alanine aminotransferase and triglycerides and lower levels of high-density lipoproteins are reported in these patients. Conclusions: We suggest performing liver US screening in subjects affected by IBD to detect NAFLD earlier. Also, patients with NAFLD present several metabolic comorbidities that would fall within the new definition of metabolic-associated fatty liver disease. Finally, we encourage larger longitudinal studies, including healthy controls, to provide further confirmation of our preliminary data. |
format | Online Article Text |
id | pubmed-10673463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106734632023-11-01 Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study Abenavoli, Ludovico Spagnuolo, Rocco Scarlata, Giuseppe Guido Maria Scarpellini, Emidio Boccuto, Luigi Luzza, Francesco Medicina (Kaunas) Brief Report Background and Objectives: Inflammatory bowel disease (IBD) is a condition characterized by chronic intestinal inflammation. We can identify two major forms: Crohn’s disease (CD) and ulcerative colitis (UC). One of the extraintestinal manifestations of IBD is nonalcoholic fatty liver disease (NAFLD). IBD and NAFLD share common pathogenetic mechanisms. Ultrasound (US) examination is the most commonly used imaging method for the diagnosis of NAFLD. This cross-sectional observational retrospective study aimed to evaluate the US prevalence of NAFLD in IBD patients and their clinical features. Materials and Methods: A total of 143 patients with IBD underwent hepatic US and were divided into two different groups according to the presence or absence of NAFLD. Subsequently, new exclusion criteria for dysmetabolic comorbidities (defined as plus) were applied. Results: The US prevalence of NAFLD was 23% (21% in CD and 24% in UC, respectively). Most IBD–NAFLD patients were male and older and showed significantly higher values for body mass index, waist circumference, disease duration, and age at onset than those without NAFLD. IBD–NAFLD patients showed a significantly higher percentage of stenosing phenotype and left-side colitis. Regarding metabolic features, IBD–NAFLD patients showed a significantly higher percentage of hypertension and IBD plus dysmetabolic criteria. Also, higher values of alanine aminotransferase and triglycerides and lower levels of high-density lipoproteins are reported in these patients. Conclusions: We suggest performing liver US screening in subjects affected by IBD to detect NAFLD earlier. Also, patients with NAFLD present several metabolic comorbidities that would fall within the new definition of metabolic-associated fatty liver disease. Finally, we encourage larger longitudinal studies, including healthy controls, to provide further confirmation of our preliminary data. MDPI 2023-11-01 /pmc/articles/PMC10673463/ /pubmed/38003983 http://dx.doi.org/10.3390/medicina59111935 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Abenavoli, Ludovico Spagnuolo, Rocco Scarlata, Giuseppe Guido Maria Scarpellini, Emidio Boccuto, Luigi Luzza, Francesco Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study |
title | Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study |
title_full | Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study |
title_fullStr | Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study |
title_full_unstemmed | Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study |
title_short | Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study |
title_sort | ultrasound prevalence and clinical features of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: a real-life cross-sectional study |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673463/ https://www.ncbi.nlm.nih.gov/pubmed/38003983 http://dx.doi.org/10.3390/medicina59111935 |
work_keys_str_mv | AT abenavoliludovico ultrasoundprevalenceandclinicalfeaturesofnonalcoholicfattyliverdiseaseinpatientswithinflammatoryboweldiseasesareallifecrosssectionalstudy AT spagnuolorocco ultrasoundprevalenceandclinicalfeaturesofnonalcoholicfattyliverdiseaseinpatientswithinflammatoryboweldiseasesareallifecrosssectionalstudy AT scarlatagiuseppeguidomaria ultrasoundprevalenceandclinicalfeaturesofnonalcoholicfattyliverdiseaseinpatientswithinflammatoryboweldiseasesareallifecrosssectionalstudy AT scarpelliniemidio ultrasoundprevalenceandclinicalfeaturesofnonalcoholicfattyliverdiseaseinpatientswithinflammatoryboweldiseasesareallifecrosssectionalstudy AT boccutoluigi ultrasoundprevalenceandclinicalfeaturesofnonalcoholicfattyliverdiseaseinpatientswithinflammatoryboweldiseasesareallifecrosssectionalstudy AT luzzafrancesco ultrasoundprevalenceandclinicalfeaturesofnonalcoholicfattyliverdiseaseinpatientswithinflammatoryboweldiseasesareallifecrosssectionalstudy |